{
  "api_version": "1",
  "request": {
    "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Candidate-1",
    "query": {
      "intervention": "Candidate-1"
    },
    "page_size": 10
  },
  "pagination": {
    "page": 1,
    "page_size": 10,
    "total_count": 3,
    "total_pages": 1,
    "next_page_url": null,
    "previous_page_url": null
  },
  "source": "remote",
  "last_synced_at": "2026-09-06T17:20:34.020Z",
  "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.",
  "notes": [
    "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.",
    "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.",
    "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees."
  ],
  "trials": [
    {
      "nct_id": "NCT05489328",
      "title": "Safety and Immunogenicity of Pneumococcal Conjugate Formulations in Healthy Adults 18 Through 49 Years of Age",
      "overall_status": "COMPLETED",
      "study_type": "INTERVENTIONAL",
      "phases": [
        "PHASE1"
      ],
      "conditions": [
        "Pneumococcal Disease"
      ],
      "interventions": [
        {
          "name": "Candidate-1",
          "type": "OTHER"
        },
        {
          "name": "Candidate-2",
          "type": "OTHER"
        },
        {
          "name": "Candidate-3",
          "type": "OTHER"
        },
        {
          "name": "Candidate-4",
          "type": "OTHER"
        },
        {
          "name": "Candidate-5",
          "type": "OTHER"
        },
        {
          "name": "Candidate-6",
          "type": "OTHER"
        },
        {
          "name": "Candidate Control",
          "type": "OTHER"
        },
        {
          "name": "13vPnC",
          "type": "BIOLOGICAL"
        },
        {
          "name": "PCV15",
          "type": "BIOLOGICAL"
        }
      ],
      "intervention_types": [
        "OTHER",
        "BIOLOGICAL"
      ],
      "sponsor": "Pfizer",
      "sponsor_class": "INDUSTRY",
      "healthy_volunteers": true,
      "eligibility": {
        "minimum_age": "18 Years",
        "maximum_age": "49 Years",
        "sex": "ALL",
        "summary": "18 Years to 49 Years"
      },
      "enrollment_count": 394,
      "start_date": "2022-08-15",
      "completion_date": "2022-10-07",
      "has_results": true,
      "last_update_posted_date": "2024-04-18",
      "last_synced_at": "2026-09-06T17:20:34.020Z",
      "location_count": 18,
      "location_summary": "Tustin, California • Walnut Creek, California • Milford, Connecticut + 12 more",
      "locations": [
        {
          "city": "Tustin",
          "state": "California"
        },
        {
          "city": "Walnut Creek",
          "state": "California"
        },
        {
          "city": "Milford",
          "state": "Connecticut"
        },
        {
          "city": "Fort Lauderdale",
          "state": "Florida"
        },
        {
          "city": "Hialeah",
          "state": "Florida"
        }
      ],
      "official_url": "https://clinicaltrials.gov/study/NCT05489328"
    },
    {
      "nct_id": "NCT07431853",
      "title": "A Study to Learn About mRNA Vaccines Against Influenza in Adults",
      "overall_status": "RECRUITING",
      "study_type": "INTERVENTIONAL",
      "phases": [
        "PHASE2"
      ],
      "conditions": [
        "Healthy Adults"
      ],
      "interventions": [
        {
          "name": "Vaccine Candidate #1",
          "type": "BIOLOGICAL"
        },
        {
          "name": "Vaccine Candidate #2",
          "type": "BIOLOGICAL"
        },
        {
          "name": "Vaccine Candidate #3",
          "type": "BIOLOGICAL"
        },
        {
          "name": "Vaccine Candidate #4",
          "type": "BIOLOGICAL"
        },
        {
          "name": "Vaccine Candidate #5",
          "type": "BIOLOGICAL"
        },
        {
          "name": "Vaccine Candidate #6",
          "type": "BIOLOGICAL"
        },
        {
          "name": "TIV1 or TIV2",
          "type": "BIOLOGICAL"
        }
      ],
      "intervention_types": [
        "BIOLOGICAL"
      ],
      "sponsor": "Pfizer",
      "sponsor_class": "INDUSTRY",
      "healthy_volunteers": true,
      "eligibility": {
        "minimum_age": "18 Years",
        "maximum_age": null,
        "sex": "ALL",
        "summary": "18 Years and older"
      },
      "enrollment_count": 770,
      "start_date": "2026-02-23",
      "completion_date": "2027-06-22",
      "has_results": false,
      "last_update_posted_date": "2026-05-06",
      "last_synced_at": "2026-09-06T17:20:34.020Z",
      "location_count": 15,
      "location_summary": "Mobile, Alabama • Walnut Creek, California • Milford, Connecticut + 12 more",
      "locations": [
        {
          "city": "Mobile",
          "state": "Alabama"
        },
        {
          "city": "Walnut Creek",
          "state": "California"
        },
        {
          "city": "Milford",
          "state": "Connecticut"
        },
        {
          "city": "Washington D.C.",
          "state": "District of Columbia"
        },
        {
          "city": "Hialeah",
          "state": "Florida"
        }
      ],
      "official_url": "https://clinicaltrials.gov/study/NCT07431853"
    },
    {
      "nct_id": "NCT05703607",
      "title": "A Study to Learn About a Modified RNA Vaccine Against Shingles in Healthy Adults",
      "overall_status": "TERMINATED",
      "study_type": "INTERVENTIONAL",
      "phases": [
        "PHASE1",
        "PHASE2"
      ],
      "conditions": [
        "Shingles",
        "Herpes Zoster Infection",
        "Human"
      ],
      "interventions": [
        {
          "name": "Candidate 1: PF-07915234: VZV modRNA Powder for Suspension for Injection",
          "type": "BIOLOGICAL"
        },
        {
          "name": "Candidate 1: PF-07915234: VZV modRNA Suspension for Injection",
          "type": "BIOLOGICAL"
        },
        {
          "name": "Candidate 2: PF-07921188: VZV modRNA Suspension for Injection",
          "type": "BIOLOGICAL"
        },
        {
          "name": "Candidate 3: PF-07921186: VZV modRNA Suspension for Injection",
          "type": "BIOLOGICAL"
        },
        {
          "name": "Shingrix",
          "type": "BIOLOGICAL"
        },
        {
          "name": "Candidate 2: PF-07921188: VZV modRNA Powder for Suspension for Injection",
          "type": "BIOLOGICAL"
        }
      ],
      "intervention_types": [
        "BIOLOGICAL"
      ],
      "sponsor": "Pfizer",
      "sponsor_class": "INDUSTRY",
      "healthy_volunteers": true,
      "eligibility": {
        "minimum_age": "50 Years",
        "maximum_age": "85 Years",
        "sex": "ALL",
        "summary": "50 Years to 85 Years"
      },
      "enrollment_count": 484,
      "start_date": "2023-01-25",
      "completion_date": "2025-09-23",
      "has_results": false,
      "last_update_posted_date": "2026-05-04",
      "last_synced_at": "2026-09-06T17:20:34.020Z",
      "location_count": 35,
      "location_summary": "Gilbert, Arizona • Mesa, Arizona • Palo Alto, California + 24 more",
      "locations": [
        {
          "city": "Gilbert",
          "state": "Arizona"
        },
        {
          "city": "Mesa",
          "state": "Arizona"
        },
        {
          "city": "Palo Alto",
          "state": "California"
        },
        {
          "city": "Walnut Creek",
          "state": "California"
        },
        {
          "city": "Washington D.C.",
          "state": "District of Columbia"
        }
      ],
      "official_url": "https://clinicaltrials.gov/study/NCT05703607"
    }
  ]
}